DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Kevin Caliendo - 3 Caliendo - 2 Wall Street's - 1 Goldman Sachs - 1 Toshiya Hari - 1 McDonald's - 1 Morgan Stanley - 1 Joseph Moore - 1
Top related locs:
Gaza mgt Burlington Carvana CY24 seasonality optionality Maxx
Top related orgs:
UBS - 4 CNBC - 3 CVS Health - 2 CVS - 2 Intel - 1 Intel Intel - 1 Nvidia - 1 JPMorgan - 1

Search resuls for: "Kevin Caliendo"


5 mentions found


☆ These big, well-known stocks are forming the dreaded death cross chart pattern
  + stars: | 2024-05-03 | by ( Pia Singh Nick Wells | Pia Singh | Nick Wells | ) www.cnbc.com   time to read: +2 min
A handful of stocks are entering or about to enter the worrisome so-called death cross. A death cross can also be indicative of a forthcoming bear market pattern. Intel Intel disappointed Wall Street's first-quarter expectations last week, when it posted a beat in earnings per share but came up light in revenue. McDonald's McDonald's has also drawn a death cross. CVS Health Unlike the other two names, CVS Health is nearing a death cross.
Persons: Wall Street's, Goldman Sachs, Toshiya Hari, McDonald's, Kevin Caliendo, Caliendo Organizations: Intel, CNBC, Intel Intel, Nvidia, CVS Health, CVS, UBS Locations: Gaza, mgt
☆ Thursday's analyst calls: Discount retailers upgraded, more good news for Carvana, tough outlook for CVS
  + stars: | 2024-05-02 | by ( Hakyung Kim | ) www.cnbc.com   time to read: +8 min
Thursday's analyst calls feature upgrades to discount retailers TJX and Burlington and used car outlet Carvana, while there was more bad news for CVS Health following a tough earnings report Wednesday. He also raised his price target to $130 from $70, or 49.2% above Wednesday's close price. He lowered his price target by $25 to $60, or just 5.6% higher from Wednesday's close price. Analyst Jay Sole also lifted his price target to $132 from $104, indicating nearly 41% upside from Wednesday's close. He raised his price target to $212 from $126, suggesting shares could gain 19.1% from where they closed Wednesday.
Persons: Morgan Stanley, Joseph Moore, Moore, Samik Chatterjee, Chatterjee, Tal Liani, Liani, — Hakyung Kim, JPMorgan Carvana, Rajat Gupta, Gupta, Kevin Caliendo, Caliendo, Jay Sole, Sole, BURL, — Hakyung Kim —, Michael Bloom Organizations: CNBC, CVS Health, UBS, CVS, JPMorgan, Qualcomm, Wall Street, Samsung, Huawei, Edge, headwinds, " Bank of America, Microsoft, Burlington Discount, TJX Companies, Burlington Stores, Burlington Locations: Burlington, Carvana, CY24, seasonality, optionality, Maxx
☆ Here are the most oversold stocks due for a bounce following the market's tough week
  + stars: | 2023-10-27 | by ( Pia Singh | ) www.cnbc.com   time to read: +4 min
The Nasdaq and the S & P 500 are each on pace for declines of about 2.5%. Some stocks hit by this week's losses have become oversold — and could be due for a bounce. Align Technology , another company that has taken a heavy beating to its stock price this week, could also be due for a comeback, based on analysts' price targets. The company's third-quarter results fell short of analysts' expectations , and a slate of analysts cut their price targets following the release. Analysts covering the stock forecast a 4.6% upside for the company's stock price, and less than 30% rate it a buy.
Persons: bode, Kevin Caliendo, Tesla, Henry Schein, Lockheed Martin, RTX, Greg Hayes, — CNBC's Michael Bloom Organizations: Tesla, Moderna, Nasdaq, Dow Jones, CNBC, Technology, UBS, Southwest Airlines, Aerospace, Lockheed, Dollar, Dwight, Marathon Oil, Allstate Locations: Covid, Ukraine, Israel
☆ This U.S. stock has risen 10% every year for the past decade — and analysts see more upside ahead
  + stars: | 2023-06-14 | by ( Ganesh Rao | ) www.cnbc.com   time to read: +3 min
U.S. health insurance firm Humana is the only major stock from around the world to have risen by more than 10% every year for the past decade. Here's what some are saying: Deutsche Bank Equity analyst George Hill bumped up the bank's price target to $568 (10% upside) on April 26. RBC Capital Markets Ben Hendrix retired the bank's outperform rating and price target of $637 on April 27. The investment bank maintains an "in-line" or hold rating on the stock with a price target of $637. Jefferies' analysts raised their price target to $614 with a buy-rating on April 27.
Persons: —, Humana's, George Hill, JP Morgan Lisa Gill, HUM, UBS Kevin Caliendo, Ben Hendrix, Morgan Stanley's, Jefferies Organizations: Humana, CNBC Pro, Affordable, NYSE, Deutsche Bank Equity, MLR, UBS, Swiss, Medicare, RBC Locations: Kentucky, U.S
☆ UBS says these stocks posted high-quality earnings this season
  + stars: | 2023-02-22 | by ( Sarah Min | ) www.cnbc.com   time to read: +3 min
Now that Wall Street is about to close the books on yet another earnings season, it's time to see which names posted higher-quality earnings than others, according to UBS. In the S & P 500, about 86% of companies reported quarterly earnings thus far, according to FactSet data. However, UBS' strategist Keith Parker worries that earnings quality is an "overhang," saying the divide between earnings and operating cash flow for companies points to roughly 15% earnings-per-share downside for at-risk stocks. These stocks are in the S & P 1500, have a market cap greater than $3 billion, excluding stocks in financial, real estate and utilities. Meanwhile, Humana demonstrated strong earnings quality because of its leading position in the Medicare Advantage market, according to UBS analyst Kevin Caliendo.
0 next >>
Total: 5